Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

379 ARTÍCULOS , VIENDO DEL 106 AL 120

The evolution of amidine-based brain penetrant BACE1 inhibitors

Oehlrich D, Prokopcova H, Gijsen HJ.

Bioorg Med Chem Lett. 2014 May 1;24(9):2033-45. doi: 10.1016/j.bmcl.2014.03.025. Epub 2014 Mar 20.

Molecular and cellular mechanism of okadaic acid (OKA)-induced neurotoxicity: a novel tool for Alzheimer's disease therapeutic application

Kamat PK, Rai S, Swarnkar S, Shukla R, Nath C.

Mol Neurobiol. 2014 Dec;50(3):852-65. doi: 10.1007/s12035-014-8699-4. Epub 2014 Apr 8.

Insights and ideas garnered from marine metabolites for development of dual-function acetylcholinesterase and amyloid-β aggregation inhibitors

Stoddard SV, Hamann MT, Wadkins RM.

Mar Drugs. 2014 Apr 4;12(4):2114-31. doi: 10.3390/md12042114.

Alzheimer's disease, enzyme targets and drug discovery struggles: from natural products to drug prototypes

Silva T, Reis J, Teixeira J, Borges F.

Ageing Res Rev. 2014 May;15:116-45. doi: 10.1016/j.arr.2014.03.008. Epub 2014 Apr 13.

[Tolerability and efficacy of the long-term administration of memantine hydrochloride (Memary®) in patients with moderate to severe Alzheimer's disease]

Kitamura S, Nakamura Y, Homma A, Kimura N, Asami Y.

Nihon Ronen Igakkai Zasshi. 2014;51(1):74-84. doi: 10.3143/geriatrics.51.74.

Aberrant expression of RCAN1 in Alzheimer's pathogenesis: a new molecular mechanism and a novel drug target

Wu Y, Ly PT, Song W.

Mol Neurobiol. 2014 Dec;50(3):1085-97. doi: 10.1007/s12035-014-8704-y. Epub 2014 Apr 22.

Drug treatments for Alzheimer's disease

Jackson GA.

Nurs Times. 2014 Feb 26-Mar 4;110(9):24-6.

Clinical trials of intravenous immunoglobulin for Alzheimer's disease

Relkin N.

J Clin Immunol. 2014 Jul;34 Suppl 1:S74-9. doi: 10.1007/s10875-014-0041-4. Epub 2014 Apr 24.

Cardiovascular effects of drugs used to treat Alzheimer's disease

Howes LG.

Drug Saf. 2014 Jun;37(6):391-5. doi: 10.1007/s40264-014-0161-z.

Immunomodulation and AD--down but not out

Knight EM, Gandy S.

J Clin Immunol. 2014 Jul;34 Suppl 1:S70-3. doi: 10.1007/s10875-014-0039-y. Epub 2014 Apr 30.

Aβ dimers differ from monomers in structural propensity, aggregation paths and population of synaptotoxic assemblies

O'Malley TT, Oktaviani NA, Zhang D, Lomakin A, O'Nuallain B, Linse S, Benedek GB, Rowan MJ, Mulder FA, Walsh DM.

Biochem J. 2014 Aug 1;461(3):413-26. doi: 10.1042/BJ20140219.

Pharmacokinetic and pharmacodynamic evaluation of donepezil for the treatment of Alzheimer's disease

Prvulovic D, Schneider B.

Expert Opin Drug Metab Toxicol. 2014 Jul;10(7):1039-50. doi: 10.1517/17425255.2014.915028. Epub 2014 Apr 30.

ACE overexpression in myelomonocytic cells: effect on a mouse model of Alzheimer's disease

Koronyo-Hamaoui M, Shah K, Koronyo Y, Bernstein E, Giani JF, Janjulia T, Black KL, Shi PD, Gonzalez-Villalobos RA, Fuchs S, Shen XZ, Bernstein KE.

Curr Hypertens Rep. 2014 Jul;16(7):444. doi: 10.1007/s11906-014-0444-x.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias